• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项来自意大利北部萨科医院 COVID19 注册研究(SMACORE)的关于 2019 冠状病毒病院内死亡的竞争风险分析

Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE).

机构信息

U.O.C. Malattie Infettive I Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy.

Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.

出版信息

Sci Rep. 2021 Jan 13;11(1):1137. doi: 10.1038/s41598-020-80679-2.

DOI:10.1038/s41598-020-80679-2
PMID:33441892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7806993/
Abstract

An accurate prediction of the clinical outcomes of European patients requiring hospitalisation for Coronavirus Disease 2019 (COVID-19) is lacking. The aim of the study is to identify predictors of in-hospital mortality and discharge in a cohort of Lombardy patients with COVID-19. All consecutive hospitalised patients from February 21st to March 30th, 2020, with confirmed COVID-19 from the IRCCS Policlinico San Matteo, Pavia, Lombardy, Italy, were included. In-hospital mortality and discharge were evaluated by competing risk analysis. The Fine and Gray model was fitted in order to estimate the effect of covariates on the cumulative incidence functions (CIFs) for in-hospital mortality and discharge. 426 adult patients [median age 68 (IQR 56 to 77 years)] were admitted with confirmed COVID-19 over a 5-week period; 292 (69%) were male. By 21 April 2020, 141 (33%) of these patients had died, 239 (56%) patients had been discharged and 46 (11%) were still hospitalised. Among these 46 patients, updated as of 30 May, 2020, 5 (10.9%) had died, 8 (17.4%) were still in ICU, 12 (26.1%) were transferred to lower intensity care units and 21 (45.7%) were discharged. Regression on the CIFs for in-hospital mortality showed that older age, male sex, number of comorbidities and hospital admission after March 4th were independent risk factors associated with in-hospital mortality. Older age, male sex and number of comorbidities definitively predicted in-hospital mortality in hospitalised patients with COVID-19.

摘要

对于需要住院治疗的 2019 年冠状病毒病(COVID-19)的欧洲患者的临床结局进行准确预测尚缺乏相关研究。本研究旨在确定意大利伦巴第地区 COVID-19 住院患者的住院死亡率和出院率的预测因素。该研究纳入了 2020 年 2 月 21 日至 3 月 30 日期间从意大利帕维亚圣马特奥综合医院确诊为 COVID-19 的连续住院患者。通过竞争风险分析评估住院死亡率和出院率。使用 Fine 和 Gray 模型来估计协变量对住院死亡率和出院率的累积发生率函数(CIF)的影响。在 5 周的时间内,共有 426 名成年患者(中位年龄 68 岁(IQR 56 至 77 岁))被确诊为 COVID-19 并住院治疗;292 名(69%)为男性。截至 2020 年 4 月 21 日,其中 141 名(33%)患者死亡,239 名(56%)患者出院,46 名(11%)仍在住院治疗。在这 46 名患者中,截至 2020 年 5 月 30 日更新数据显示,5 名(10.9%)患者死亡,8 名(17.4%)仍在 ICU,12 名(26.1%)转至低强度护理病房,21 名(45.7%)出院。CIF 分析表明,年龄较大、男性、合并症数量以及 3 月 4 日后住院是与住院死亡率相关的独立危险因素。年龄较大、男性和合并症数量是 COVID-19 住院患者住院死亡率的明确预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2696/7806993/0c5c10103660/41598_2020_80679_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2696/7806993/95f266e68fd0/41598_2020_80679_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2696/7806993/0c5c10103660/41598_2020_80679_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2696/7806993/95f266e68fd0/41598_2020_80679_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2696/7806993/0c5c10103660/41598_2020_80679_Fig2_HTML.jpg

相似文献

1
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE).一项来自意大利北部萨科医院 COVID19 注册研究(SMACORE)的关于 2019 冠状病毒病院内死亡的竞争风险分析
Sci Rep. 2021 Jan 13;11(1):1137. doi: 10.1038/s41598-020-80679-2.
2
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
3
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
4
The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort.肥胖悖论:来自 SMAtteo COvid-19 REgistry(SMACORE)队列的分析。
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1920-1925. doi: 10.1016/j.numecd.2020.07.047. Epub 2020 Aug 11.
5
Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE).托珠单抗治疗重症COVID-19患者:来自SMAtteo COvid19 REgistry(SMACORE)的初步结果
Microorganisms. 2020 May 9;8(5):695. doi: 10.3390/microorganisms8050695.
6
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use.预测 2019 年冠状病毒病的院内死亡率:一个简单的经验证的临床应用应用程序。
PLoS One. 2021 Jan 14;16(1):e0245281. doi: 10.1371/journal.pone.0245281. eCollection 2021.
7
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19.老年 COVID-19 住院患者院内死亡的临床特征和预测因素。
Age Ageing. 2021 Feb 26;50(2):326-334. doi: 10.1093/ageing/afaa258.
8
Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.意大利伦巴第地区 COVID-19 疫苗接种与入住重症监护病房以及 COVID-19 肺炎重症患者结局的相关性。
JAMA Netw Open. 2022 Oct 3;5(10):e2238871. doi: 10.1001/jamanetworkopen.2022.38871.
9
[Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].[新冠疫情对弗留利-威尼斯朱利亚大区(意大利北部)的影响:通过竞争风险分析评估与死亡风险相关的因素]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):128-135. doi: 10.19191/EP20.5-6.S2.111.
10
Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data.英格兰 COVID-19 住院患者病死率的相关患者因素和时间趋势:基于行政数据的观察性研究。
Lancet Respir Med. 2021 Apr;9(4):397-406. doi: 10.1016/S2213-2600(20)30579-8. Epub 2021 Feb 15.

引用本文的文献

1
Joint modeling of longitudinal and competing risks for assessing blood oxygen saturation and its association with survival outcomes in COVID-19 patients.用于评估新冠肺炎患者血氧饱和度及其与生存结局关联的纵向和竞争风险联合建模
J Educ Health Promot. 2024 Mar 28;13:91. doi: 10.4103/jehp.jehp_246_23. eCollection 2024.
2
Effectiveness of regdanvimab on mortality in COVID-19 infected patients on hemodialysis.瑞格丹维单抗对接受血液透析的COVID-19感染患者死亡率的有效性。
Kidney Res Clin Pract. 2024 Jan;43(1):111-121. doi: 10.23876/j.krcp.23.137. Epub 2024 Jan 23.
3
Management of Patients Affected by Giant Cell Arteritis during the COVID-19 Pandemic: Telemedicine Protocol TELEMACOV.

本文引用的文献

1
Prediction of in-hospital mortality of patients with SARS-CoV-2 infection by comorbidity indexes: an Italian internal medicine single center study.通过合并症指数预测新型冠状病毒2感染患者的院内死亡率:一项意大利内科单中心研究
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10258-10266. doi: 10.26355/eurrev_202010_23250.
2
Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎的流行病学、合并症因素与严重程度及预后:一项系统综述和荟萃分析
Aging (Albany NY). 2020 Jul 13;12(13):12493-12503. doi: 10.18632/aging.103579.
3
Covid-19: A Dynamic Analysis of Fatality Risk in Italy.
2019冠状病毒病大流行期间巨细胞动脉炎患者的管理:远程医疗协议TELEMACOV
J Pers Med. 2023 Mar 31;13(4):620. doi: 10.3390/jpm13040620.
4
The Dynamics of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict Progression to Septic Shock and Death in Patients with Prolonged Intensive Care Unit Stay.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值的动态变化可预测 ICU 住院时间延长患者进展为感染性休克和死亡。
Medicina (Kaunas). 2022 Dec 23;59(1):32. doi: 10.3390/medicina59010032.
5
Long-Term Effects of Hospitalization for COVID-19 on Frailty and Quality of Life in Older Adults ≥80 Years.新型冠状病毒肺炎住院治疗对80岁及以上老年人虚弱状态和生活质量的长期影响
J Clin Med. 2022 Sep 29;11(19):5787. doi: 10.3390/jcm11195787.
6
The role of electrolyte imbalances in predicting the severity of COVID-19 in the hospitalized patients: a cross-sectional study.电解质失衡在预测住院 COVID-19 患者严重程度中的作用:一项横断面研究。
Sci Rep. 2022 Aug 30;12(1):14732. doi: 10.1038/s41598-022-19264-8.
7
COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles.危重症患者中的新冠病毒变异株:德尔塔变异株与奥密克戎变异株特征比较
Infect Dis Rep. 2022 Jun 17;14(3):492-500. doi: 10.3390/idr14030052.
8
Handling death as an intercurrent event in time to recovery analysis in COVID-19 treatment clinical trials.将死亡作为 COVID-19 治疗临床试验中时间到恢复分析的伴随事件进行处理。
Contemp Clin Trials. 2022 Aug;119:106758. doi: 10.1016/j.cct.2022.106758. Epub 2022 Apr 6.
9
Frailty in Elderly Patients with Covid-19: A Narrative Review.新型冠状病毒肺炎老年患者的衰弱:一项叙述性综述。
Gerontol Geriatr Med. 2022 Mar 4;8:23337214221079956. doi: 10.1177/23337214221079956. eCollection 2022 Jan-Dec.
10
Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study.年龄是 COVID-19 相关住院死亡率的主要决定因素,而既往合并症的影响最小,这是一项回顾性队列研究。
BMC Geriatr. 2022 Mar 5;22(1):184. doi: 10.1186/s12877-021-02673-1.
新冠疫情:意大利死亡风险的动态分析。
Front Med (Lausanne). 2020 Apr 30;7:185. doi: 10.3389/fmed.2020.00185. eCollection 2020.
4
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素:系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
5
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
6
Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus.住院感染甲型 H7N9 禽流感病毒患者的心脏损伤与死亡率的关系。
Crit Care Med. 2020 Apr;48(4):451-458. doi: 10.1097/CCM.0000000000004207.
7
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre.意大利北部对新冠疫情的快速响应:如何将一个传统传染病病房改造成新冠疫情应对中心。
J Hosp Infect. 2020 Mar 20;105(3):477-9. doi: 10.1016/j.jhin.2020.03.020.
8
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎的临床、实验室和影像学特征:系统评价和荟萃分析。
Travel Med Infect Dis. 2020 Mar-Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13.
9
COVID-19 and Italy: what next?COVID-19 和意大利:下一步如何?
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
10
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响:系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.